Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Janssen’s Ponesimod OPTIMUM trial in MS meets primary endpoint Ponesimod OPTIMUM trial results :Â Johnson & Johnson’s Janssen Pharmaceutical said that the phase 3 OPTIMUM clinical trial… bypharmanewsdailyJuly 29, 2019